Reuters: Intranasal Vaccine Aims to Block Virus at Point of Entry

Jul 20, 2021
1 min read

An experimental intranasal COVID-19 vaccine now being tested for the first time in humans showed promising results in monkeys, researchers will report on Thursday at ASV 2021, the annual meeting of the American Society of Virology.

To read the full article, click here.

Recent Posts

See All

The Scientist: Nasal Vaccines Are Commercially High Risk, Perhaps High Reward

In her reporting of the nasal vaccine landscape space, Jef Akst, managing editor of The Scientist, covered Meissa's intranasal live...

Bloomberg BusinessWeek: Why Nasal Sprays Are Poised to Be the Next Weapon for Fighting Covid

Excerpt from the article: Half a Greek alphabet and two years into the pandemic, the world is coming to terms with the notion that...

The Washington Post: The Next Leap in Coronavirus Vaccine Development Could Be a Nasal Spray

Excerpt from WaPo ------- As the omicron variant of the coronavirus moved lightning-fast around the world, it revealed an unsettling...

Comments